Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Patient Capital Management Opportunity Equity’s Q1 2024 Investor Letter

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2024 investor letter. During the quarter the strategy returned 11.8% net of fees compared to the S&P 500’s 10.6% return. The outperformance of the portfolio can be attributed to selection and allocation effects, which are partially counteracted by interaction effects, according to a three-factor performance attribution model. In addition, you can check the top 5 holdings of the fund to know its best picks in 2024.

A copy of Patient Capital Management...